Pharmaceutical News

New Migraine Treatment Now Available on NHS for Some Patients

/ June 14, 2026

A new migraine treatment called Aquipta (atogepant) has been approved by the National Institute for Health and Care Excellence (NICE) […]

/ June 13, 2026

The UK’s medicines regulator, the Medicines and Healthcare products Regulatory Agency (MHRA), is starting a new program using artificial intelligence

/ June 12, 2026

A Swedish biotech company called Anocca has started the first tests in humans of a new experimental cancer treatment called

/ June 10, 2026

Johnson & Johnson recently shared early results from a clinical trial (called the JASMINE study) that tested a new medication

/ June 9, 2026

A recent court decision in the United States has forced Japanese drugmaker Takeda to report a significant financial loss for

/ June 8, 2026

A recent clinical trial for Zynlonta, a medication used to treat a type of blood cancer called diffuse large B-cell

/ June 7, 2026

A pharmaceutical company called Axsome Therapeutics has reached a legal agreement that will prevent other companies from selling cheaper, generic

/ June 6, 2026

A recent clinical trial has found that adding a new immunotherapy drug called durvalumab to traditional chemotherapy and radiation therapy

/ June 5, 2026

Starting January 1st, the European Union has introduced new laws to improve how chemicals are evaluated for safety. This is

/ June 3, 2026

Leading pharmaceutical companies Pfizer and Innovent Biologics have signed a major agreement to work together on developing 12 new cancer